other material
confidence high
sentiment neutral
materiality 0.60
Tango Therapeutics ups ATM equity offering to $400M, replacing $100M program
Tango Therapeutics, Inc.
- Filed new prospectus supplement Aug 11, 2026 to sell up to $400M of common stock under ATM sales agreement.
- Prior $100M ATM program terminated; ~$64.39M already sold, ~$35.61M unsold rolled into new offering.
- Sales agreement with Leerink Partners LLC remains in effect for the $400M program.
- No use-of-proceeds specified; likely general corporate purposes.